Results 1-10 of about 305|
  1. ... nih.gov/pubmed/12851279?tool=bestpractice.com Recombinant factor VII activated (rFVIIa) This new agent may be considered ... GL, et al. Potential role of recombinant activated factor VII for the treatment of severe bleeding associated with ...
    Source: BMJ Best Practice
    Information Type: Oppslagsverk
  2. ... IX) assay: decreased or absent factor levels Haemophilia Factor V, VII, X, or XI deficiency History Exam 1st investigation ... IX) assay: decreased or absent factor levels Haemophilia Factor V, VII, X, or XI deficiency History Exam 1st investigation ...
    Source: BMJ Best Practice, BMJ Best Practice
    Information Type: Oppslagsverk, Oppslagsverk
  3. ... IX) assay: decreased or absent factor levels Hemophilia Factor V, VII, X, or XI deficiency History Exam 1st investigation ... IX) assay: decreased or absent factor levels Hemophilia Factor V, VII, X, or XI deficiency History Exam 1st investigation ...
    Source: BMJ Best Practice, BMJ Best Practice
    Information Type: Oppslagsverk, Oppslagsverk
  4. ... In comparison with factor concentrates or recombinant activated factor VII, fresh frozen plasma normalises INR less quickly, is ... been suggested by experts, including emergency haemodialysis, recombinant factor VII, and/or prothrombin complex concentrate containing factor VII ( ...
    Source: BMJ Best Practice
    Information Type: Oppslagsverk
  5. ... been suggested by experts, including emergency haemodialysis, recombinant factor VII, and/or prothrombin complex concentrate containing factor VII (not available in the US). Idarucizumab is the ...
    Source: BMJ Best Practice
    Information Type: Oppslagsverk
  6. ... been suggested by experts, including emergency hemodialysis, recombinant factor VII, and/or prothrombin complex concentrate containing factor VII (not available in the US). Idarucizumab is the ...
    Source: BMJ Best Practice
    Information Type: Oppslagsverk
  7. ... increased coagulation factors and impaired fibrinolysis. Tissue factor, factors VII and VIII, and plasminogen activator inhibitor-1 are ... of coagulation and increased levels of fibrinogen and factors VII, IX, and X in current smokers compared with ...
    Source: BMJ Best Practice
    Information Type: Oppslagsverk
  8. ... X) and 4-factor preparations (which also contain factor VII). [230] Khorsand N, Kooistra HA, van Hest R, ... state. Activated PCCs contain activated, rather than inactivated, factor VII. Due to their powdered formulation and lack of ...
    Source: BMJ Best Practice
    Information Type: Oppslagsverk
  9. ... results (for example, if the PT is prolonged, factor VII and factor V assays should be checked to rule out co-existent factor VII deficiency or the rare autosomal recessive combined factor ...
    Source: BMJ Best Practice
    Information Type: Oppslagsverk
  10. ... results (for example, if the PT is prolonged, factor VII and factor V assays should be checked to rule out coexistent factor VII DIAGNOSIS 10 This PDF of the BMJ Best ...
    Source: BMJ Best Practice
    Information Type: Oppslagsverk
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last